Difference between revisions of "ANLY482 AY2016-17 T2 Group19 Findings"

From Analytics Practicum
Jump to navigation Jump to search
Line 63: Line 63:
 
<div style="text-align: justify;">
 
<div style="text-align: justify;">
 
===Cardiovascular and Hematopoietic System===
 
===Cardiovascular and Hematopoietic System===
Within this category, the top three subcategory sales, Angiotensin II Antagonists, Dyslipidaemic Agents and Calcium Antagonists were analysed on a yearly and monthly basis to discover any overall patterns and seasonal trends. Drugs belonging to Angiotensin II Antagonists and Calcium Antagonists are used primarily in the treatment of hypertension and hypertension while Dyslipidaemic Agents are used to lower abnormal levels of lipids in the bloodstream.   
+
Within this category that contributes 20% to the total sales, the top three subcategory sales, Angiotensin II Antagonists, Dyslipidaemic Agents and Calcium Antagonists were analysed on a yearly and monthly basis to discover any overall patterns and seasonal trends. Drugs belonging to Angiotensin II Antagonists and Calcium Antagonists are used primarily in the treatment of hypertension and hypertension while Dyslipidaemic Agents are used to lower abnormal levels of lipids in the bloodstream.   
  
 
[[File:Cardiovascular Yearly Sales.png|500px|center]]
 
[[File:Cardiovascular Yearly Sales.png|500px|center]]
Line 74: Line 74:
  
 
<div style="text-align: justify;">
 
<div style="text-align: justify;">
 +
 
===Genito-Urinary System===
 
===Genito-Urinary System===
  

Revision as of 18:16, 27 February 2017



Protegelogo-01.svg

Protege overview.svg   OVERVIEW

Protege data.svg   DATA

Protege Methods.svg   METHODOLOGY & ANALYSIS

Protegemaster-03.svg   FINDINGS

Protege poster.svg   DOCUMENTATION

  BACK TO COURSE

Exploratory Data Analysis

Contextual Approach

The main focus of Exploratory Data Analysis for the given dataset is to understand and to uncover any purchasing patterns relating to a variety of specific groups of customers. In that regard, our team has identified three main types of customers to focus on and has conducted their respective analyses as shown in the following diagram.

EDA Overall Trends.png


Sales Trends for Company J and S

The names of these companies have been redacted in accordance to the terms and conditions of the Non-Disclosure Agreement (NDA). Nevertheless, Company Z has been engaged by various pharmaceutical companies who wish to utilise Company Z's distribution network by selling medical products on their behalf. A comparison of their sales trends against Company Z's sales trends was done so as to gauge their performance.

Company J only sells products belonging to "Other Dermatologicals" subcategory and Company S only sells products belonging to "Vaccines, Antisera & Immunologicals" subcategory. These sales are compared to Company Z's own sales in those subcategories to better gauge their performance. Sales figures are not to be released in accordance to the terms and conditions of the NDA, however Company S sales has decreased while Company Z's sales have increased during 2014 - 2016, the opposite is observed for Company J where its own sales have increased while Company Z's sales have decreased. A possible explanation for the observed trend is that, demand for Company S's products is decreasing due to Company Z’s customers switching to their competitors products for better prices.


GP Sales Trends on a Product Level

Analysis was conducted for categories of products which contributed 10% or more to the total sales aggregated for the years 2014 - 2016.

6 Category Sales.png

We note that overall GP sales have been increasing but growth was slower in 2016 as compared to 2015. On the category level there is an overall increase in sales for all categories except Dermatological Therapy. As the thickness of the lines indicate the quantity of the products sold, it can be inferred that Genito-Urinary System products are being sold at higher prices as compared to the other categories. A possible explanation regarding the increasing trends could be that more patients are seeing GPs for treatment of diseases which fall under those categories. For the decreasing trends, one possible explanation is that patients with illnesses that can be treated with Dermatological Therapy drugs are visiting specialist clinics instead of GPs. Further investigation into each category which contributed 10% of more of total sales and their respective subcategories will be conducted to discover the revenue drivers and any existing seasonal trends if any.

Cardiovascular and Hematopoietic System

Within this category that contributes 20% to the total sales, the top three subcategory sales, Angiotensin II Antagonists, Dyslipidaemic Agents and Calcium Antagonists were analysed on a yearly and monthly basis to discover any overall patterns and seasonal trends. Drugs belonging to Angiotensin II Antagonists and Calcium Antagonists are used primarily in the treatment of hypertension and hypertension while Dyslipidaemic Agents are used to lower abnormal levels of lipids in the bloodstream.

Cardiovascular Yearly Sales.png

It is observed that sales belonging to Angiotensin II Antagonists and Calcium Antagonists are increasing while sales belonging to Dyslipidaemic Agents are decreasing. These results may be indicative of a greater prevalence of hypertension and high blood pressure coupled with a reduction in Dyslipidaemia amongst the GP’s patients. According to the data provided by Ministry of Health on the prevalence of diseases from age 18 to 69 years, hypertension saw a 23.5% incidence rate, Diabetes for 11.3%, High cholesterol for 17.4%, Obesity for 10.8% and Daily smoking for 14.3%. Of which, these diseases are widely known to be direct causes of heart problems.

Cardiovascular Trends.png

As expected, there are no observable sales trends for Cardiovascular & Hematopoietic System products except for the peaks in sales at the end of each year, possibly due to closure of offices in response to the New Year Holiday.

Genito-Urinary System

Respiratory System

Central Nervous System

Allergy & Immnue System

Dermatological Therapy

Customer Analysis

Planning Area: Subzone Analysis

Pareto Plot Analysis

Specialists

Pharmacies

Customer and Sales Trends Exploration

Product Categories

Final

Stuff